Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Thorsten Fuereder"'
Autor:
Stefano Cavalieri, Eleonora Bruno, Mara Serena Serafini, Deborah Lenoci, Silvana Canevari, Laura Lopez-Perez, Liss Hernandez, Luigi Mariani, Rosalba Miceli, Cecilia Gavazzi, Patrizia Pasanisi, Elena Rosso, Francesca Cordero, Paolo Bossi, Wojciech Golusinski, Andreas Dietz, Primož Strojan, Thorsten Fuereder, Loris De Cecco, Lisa Licitra
Publikováno v:
Frontiers in Oncology, Vol 13 (2024)
BackgroundThere is a strong need for preventive approaches to reduce the incidence of recurrence, second cancers, and late toxicities in head and neck squamous cell carcinoma (HNSCC) survivors. We conducted a randomized controlled trial (RCT) to asse
Externí odkaz:
https://doaj.org/article/6ddb8c97126d47debcf457fefba9d6d1
Autor:
Christoph Minichsdorfer, Andreas Gleiss, Marie-Bernadette Aretin, Manuela Schmidinger, Thorsten Fuereder
Publikováno v:
Annals of Medicine, Vol 54, Iss 1, Pp 1339-1349 (2022)
Background Immune checkpoint inhibitors (ICI) are regarded as a standard of care in multiple malignancies. We hypothesized that serum parameters are of prognostic value in ICI treated patients suffering from solid tumours.Methods Data from 114 patien
Externí odkaz:
https://doaj.org/article/32ffaeb780de463882eef2828667e821
Autor:
Ingeborg Klymiuk, Ceren Bilgilier, Alexander Mahnert, Andreas Prokesch, Christoph Heininger, Ingeborg Brandl, Hanka Sahbegovic, Christian Singer, Thorsten Fuereder, Christoph Steininger
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Cytotoxic chemotherapy with or without a combination of humanized monoclonal antibodies is regarded as the gold standard of personalized medicine for the treatment of breast cancer patients. Significant medication-related side effects are common acco
Externí odkaz:
https://doaj.org/article/239be78d48c54942bbe40904be480778
Autor:
Markus Haas, Alexander Lein, Thorsten Fuereder, Faris F. Brkic, Julia Schnoell, David T. Liu, Lorenz Kadletz-Wanke, Gregor Heiduschka, Bernhard J. Jank
Publikováno v:
Nutrients, Vol 15, Iss 4, p 880 (2023)
Malnutrition is a frequent comorbidity in head and neck cancer patients and has been shown to impair immunotherapy response in other cancer types. The geriatric nutritional risk index (GNRI) assesses malnutrition using the patient’s ideal weight, a
Externí odkaz:
https://doaj.org/article/cf920bab8e52403587679b504031cf14
Autor:
Matthias Preusser, Anna Sophie Berghoff, Thorsten Fuereder, Leonhard Müllauer, Gerwin Heller, Angelika Martina Starzer, Katharina Feldmann, Erwin Tomasich, Teresa Hatziioannou, Stefan Traint, Thomas Melchardt, Christoph Minichsdorfer, Ursula Schwarz-Nemec, Maja Nackenhorst
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 3 (2022)
Background Biomarkers for response prediction to anti-programmed cell death 1 (PD-1) immune checkpoint inhibitors (ICI) in patients with head and neck squamous cell carcinoma (HNSCC) are urgently needed for a personalized therapy approach. We investi
Externí odkaz:
https://doaj.org/article/e6550fd49f974f6795b61c4497460f1c
Autor:
Matthias Preusser, Hannah Christina Puhr, Anna Sophie Berghoff, Thorsten Fuereder, Florian Moik, Gerwin Heller, Helmuth Haslacher, Thomas Perkmann, Robert Strassl, Julia Maria Berger, Judith Kreminger, Lorenz Schubert, Angelika Martina Starzer, Ariane Steindl, Stefan Winkler, Selma Tobudic
Publikováno v:
ESMO Open, Vol 5, Iss 5 (2020)
Background During the COVID-19 outbreak, healthcare professionals (HCP) are at the frontline of clinical management and at increased risk for infection. The SARS-CoV-2 seroprevalence of oncological HCP and their patients has significant implications
Externí odkaz:
https://doaj.org/article/6290a4a735ba46fb9069b76abf9e3a7e
Autor:
Matthias Preusser, Aysegül Ilhan-Mutlu, Gerald Prager, Thorsten Fuereder, Christine Marosi, Markus Raderer, Barbara Kiesewetter, Anna S Berghoff, Manuela Schmidinger, Maximilian Marhold, Rupert Bartsch, Thais Topakian, Hermine Agis, Thomas Brodowicz, Michael Krainer, Gottfried J Locker, Christiane Thallinger, Sabine Zöchbauer-Müller, Wolfgang Lamm
Publikováno v:
ESMO Open, Vol 5, Iss 5 (2020)
Background Novel treatment modalities like targeted therapy and immunotherapy are currently changing treatment strategies and protocols in the field of medical oncology.Methods Numbers of patients and patient contacts admitted to medical oncology day
Externí odkaz:
https://doaj.org/article/c25a723c17b34991a47ad53813bf4e27
Autor:
Matthias Preusser, Hannah Christina Puhr, Anna Sophie Berghoff, Thorsten Fuereder, Florian Moik, Gerwin Heller, Helmuth Haslacher, Thomas Perkmann, Robert Strassl, Julia Maria Berger, Judith Kreminger, Lorenz Schubert, Angelika Martina Starzer, Ariane Steindl, Stefan Winkler, Selma Tobudic
Publikováno v:
ESMO Open, Vol 5, Iss 5 (2020)
Externí odkaz:
https://doaj.org/article/d6b51eefc0f04d66b1b093d051da201e
Autor:
Alexander Michael Grandits, Sophie Bromberger, Gerwin Heller, Barbara Andrea Reinoehl, Erwin Tomasich, Klaudia Schossleitner, Anna Sophie Berghoff, Thorsten Fuereder, Rotraud Wieser
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 3, p 1050 (2022)
Head and neck squamous cell carcinoma (HNSCC) is a frequent malignancy with a poor prognosis. So far, the EGFR inhibitor cetuximab is the only approved targeted therapy. A deeper understanding of the molecular and genetic basis of HNSCC is needed to
Externí odkaz:
https://doaj.org/article/5c67ca9054214fb29141b0668146b118
Autor:
Christoph Minichsdorfer, Felicitas Oberndorfer, Christoph Krall, Gabriela Kornek, Leonhard Müllauer, Christina Wagner, Thorsten Fuereder
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Background: Nasopharyngeal carcinoma (NPC) is endemic in East Asia but rare in the western world. Programmed death ligand 1 (PD-L1) expression on NPC correlates with clinical outcomes. However, data for Caucasian NPC patients are missing. Thus, we pe
Externí odkaz:
https://doaj.org/article/1d09d4b77857436890c2d3962d80f62e